Gilead’s Truvada faces Teva generics assault amid Descovy switching campaignMedicaloidOctober 2, 2020 October 2, 2020When its U.S. patent cliff for HIV med Truvada was still on the horizon, Gilead Sciences won approval for follow-up med Descovy and launched an aggressive...
